Kazia announces voluntary delisting from ASX

SYDNEY, Oct. 11, 2023 /PRNewswire/ -- Kazia Therapeutics Limited , an oncology-focused drug development company, announces its intention to de-list from the Australian Securities Exchange .


...

Related Keywords

Australia ,Sydney ,New South Wales ,United States ,Australian ,Karen Krumeich ,Genentech ,Nasdaq ,Australian Securities Exchange ,Kazia Therapeutics ,Consequences For The Company ,Takeovers Panel ,Company To Delist ,Exchange Commission ,Kazia Therapeutics Limited ,Company Australian ,Twitter ,Prnewswire Kazia Therapeutics Limited ,Therapeutics Limited ,Official List ,Chief Financial Officer ,Managing Director ,Interim Chairman ,Corporations Act ,Governance Principles ,Listing Rule ,Guidance Note ,Delisting Facilities ,Unacceptable Circumstances ,Orphan Drug Designation ,Fast Track Designation ,Disease Designation ,Annual Report ,United States Securities ,Markets ,